DFTX

Definium Therapeutics Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↑ 6/10
  • Momentum↑ 9/10
Definium Therapeutics sales and earnings growth
DFTX Growth
Good
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ 1.01%
  • FCF Y/Y↓ -53.26%
Definium Therapeutics gross and profit margin trends
DFTX Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↓ -120.30%
Definium Therapeutics net debt vs free cash flow
DFTX Risk
Great
  • Debt / Equity↓ 0.3
  • Debt / FCF↓ 0.2
  • Interest coverage↓ -33.5

Definium Therapeutics stock volatility is higher than the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗